According to our research analysis, Global autoimmune disease diagnostics market 2021-2031 will reach USD 10.81 billion by 2031, growing by 8.1% annually over 2021-2031, driven by the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies.
Highlighted with 87 tables and 103 figures, this 188-page report Global Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Region.
Based on Product, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
- Assay Kits & Consumables
- Analyzers & Instruments
Based on Test Type, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
Get a Free Sample Report @
Autoantibodies and Immunologic Tests
- Antinuclear Antibody Tests
- Anti-cyclic Citrullinated Peptide
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Rheumatoid Factor
- Thyroid Antibody Tests
- Other Autoantibodies and Immunologic Tests
Inflammatory Marker Tests
- C-Reactive Protein (CRP)
- Erythrocyte Sedimentation Rate (ESR)
- Other Inflammatory Marker Tests
- Routine Laboratory Tests
For More Information, refer to below link: –
Contact Us: –
Ankur Gupta, Head Marketing & Communications